AU1186695A - Reagents and methods for the detection of methotrexate - Google Patents

Reagents and methods for the detection of methotrexate

Info

Publication number
AU1186695A
AU1186695A AU11866/95A AU1186695A AU1186695A AU 1186695 A AU1186695 A AU 1186695A AU 11866/95 A AU11866/95 A AU 11866/95A AU 1186695 A AU1186695 A AU 1186695A AU 1186695 A AU1186695 A AU 1186695A
Authority
AU
Australia
Prior art keywords
methotrexate
reagents
detection
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU11866/95A
Inventor
Sherri L Juveland
Joan D Tyner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US16512193A priority Critical
Priority to US165121 priority
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Priority to PCT/US1994/013558 priority patent/WO1995016026A1/en
Publication of AU1186695A publication Critical patent/AU1186695A/en
Application status is Abandoned legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/533Production of labelled immunochemicals with fluorescent label
AU11866/95A 1993-12-10 1994-11-22 Reagents and methods for the detection of methotrexate Abandoned AU1186695A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US16512193A true 1993-12-10 1993-12-10
US165121 1993-12-10
PCT/US1994/013558 WO1995016026A1 (en) 1993-12-10 1994-11-22 Reagents and methods for the detection of methotrexate

Publications (1)

Publication Number Publication Date
AU1186695A true AU1186695A (en) 1995-06-27

Family

ID=22597511

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11866/95A Abandoned AU1186695A (en) 1993-12-10 1994-11-22 Reagents and methods for the detection of methotrexate

Country Status (5)

Country Link
EP (1) EP0733102A1 (en)
JP (1) JPH09506260A (en)
AU (1) AU1186695A (en)
CA (1) CA2178590A1 (en)
WO (1) WO1995016026A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5710009A (en) * 1994-02-17 1998-01-20 Serex, Inc. Receptor:release ligand (reland) complexes and release assays using said reland and methods and kits based thereon
WO1997040033A1 (en) * 1996-04-19 1997-10-30 Lexigen Pharmaceuticals Corp. Inhibition of the binding of human ige to its receptor by tetracyclic compounds for the alleviation of ige-mediated immune response
EP3002299A1 (en) 2008-06-03 2016-04-06 AbbVie Inc. Dual variable domain immunoglobulins and uses thereof
EP2473524A4 (en) * 2009-09-01 2013-05-22 Abbott Lab Dual variable domain immunoglobulins and uses thereof
BR112013002578A2 (en) 2010-08-03 2019-05-14 Abbvie Inc immunoglobulins dual variable domain and uses the same
BR112013004581A2 (en) 2010-08-26 2017-06-27 Abbvie Inc dual variable domain immunoglobulins and their uses
BR112014015851A2 (en) 2011-12-30 2019-09-24 Abbvie Inc double specific binding proteins directed against il-13 and / or il-17
KR20190107184A (en) 2012-11-01 2019-09-18 애브비 인코포레이티드 Anti-vegf/dll4 dual variable domain immunoglobulins and uses thereof
EP2970459A2 (en) 2013-03-15 2016-01-20 AbbVie Inc. Dual specific binding proteins directed against il-1beta and il-17
WO2016094881A2 (en) 2014-12-11 2016-06-16 Abbvie Inc. Lrp-8 binding proteins
CN104569373B (en) * 2015-01-27 2016-08-17 苏州博源医疗科技有限公司 A kind of methotrexate homogeneous enzyme immunoassay detectable and preparation thereof and detection method
TW201710286A (en) 2015-06-15 2017-03-16 艾伯維有限公司 Binding proteins against VEGF, PDGF, and/or their receptors
WO2017007889A1 (en) * 2015-07-08 2017-01-12 Defined Diagnostics, Llc Compounds and methods for the detection of methotrexate
CN107219357A (en) * 2017-04-21 2017-09-29 中国人民解放军第三军医大学第附属医院 A kind of ELISA kit for detecting methotrexate (MTX) and its application

Also Published As

Publication number Publication date
EP0733102A1 (en) 1996-09-25
WO1995016026A1 (en) 1995-06-15
JPH09506260A (en) 1997-06-24
CA2178590A1 (en) 1995-06-15

Similar Documents

Publication Publication Date Title
AU666709B2 (en) Pyrimidine derivatives and processes for the preparation thereof
AU680520B2 (en) Diagnostic reagent stabilizer
AU703110C (en) Modified factor VII
AU642745B2 (en) Particle detection
AU697251B2 (en) Leakage detection
AU666227B2 (en) Process and installation for the separation of solid-liquid-mixtures
EP0745128B8 (en) Hepatitis b virus mutants, reagents and methods for detection
AU692484B2 (en) 1N-alkyl-N-arylpyrimidinamines and derivatives thereof
AU696235C (en) Anti-GP39 antibodies and uses therefor
AU684585B2 (en) Interrupted-flow assay device
AU695349B2 (en) Tag reagent and assay method
AU663683B2 (en) Coagulation assays and reagents
GB2281047B (en) Structural member and method for forming the same
AU694437B2 (en) Device for detecting the presence of persons on seats
AU6017994A (en) Language-sensitive collation system
AU3637495A (en) Navigation apparatus with attitude determination
AU7007194A (en) Method and apparatus for the formation of particles
AU4366596A (en) Fugitive emissions detection system and components thereof
EP0752688A3 (en) Road distances identifying device
AU6956094A (en) Modified factor vii
GR3019617T3 (en) DNA detection method
AU5932896A (en) Systems and methods for separating erythrocytes
AU5526696A (en) Substrates for beta-lactamase and uses thereof
AU7714394A (en) Solvent soaps and methods employing same
AU7505494A (en) Liquid/solid separation